Letter to the Editor: Comment on: “Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non‐Mapping Patients”

Documenti analoghi

• Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?
  di: Kristel Lourdault, et al.
  Pubblicazione: (2024)
• Omission of Sentinel Lymph Node Biopsy in Breast Cancer: A Real‐World Validation of the Patient Populations of the SOUND and INSEMA Trials
  di: Tia Puiras, et al.
  Pubblicazione: (2026)
• Cost‐Utility Analysis of Indocyanine Green Versus Methylene Blue for Sentinel Lymph Node Biopsy in Breast Cancer
  di: Sonia H. Lee, et al.
  Pubblicazione: (2026)
• Lymph Node Dissection for Melanoma: Contemporary Trends in Postoperative Outcomes and Patient Selection With Reduced Case Volumes in the Post‐MSLT2 Era
  di: Mohammad S. Farooq, et al.
  Pubblicazione: (2025)
• Indocyanine Green–Guided Sentinel Lymph Node Biopsy in Melanoma: Assessing Clinical Value in a Cohort Over 1000 Patients
  di: Daniela Duarte‐Bateman, et al.
  Pubblicazione: (2026)